These results evidence that FFAR3 loss is still sufficient to prevent AD-related cognitive dysfunction even in the scenario of a dietary metabolic challenge, again reinforcing the view of an enhanced metabolic resilience of Tg-FFAR3−/− mice. This evidence concerns the gene FFAR3 and Alzheimer disease.